AVR.AU Anteris Technologies Global Corp

Healthcare Health Care Equipment & Supplies Australian Securities Exchange
8.83 AUD
Close of Nov 1, 2026
5.20 15.47
Market cap
AUD 860M
P/E
-
P/B
2.41x
ROE
-59.8%
Dividend yield
-
Fundamental score
1.4/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is AVR.AU undervalued?

Graham number

The Graham number of Anteris Technologies Global Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Anteris Technologies Global Corp fundamental analysis

7 of 21 checks passed

ROE 0/2

Low return on equity (-59.8%), below 10%.

ROA 0/1

Return on assets (-55.1%) is below the industry median (-35.3%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (30.7%) is above the industry median (24.9%).

Revenue Growth 0/2

Revenue shrank 25.3% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (1.3%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Cash Runway 1/2

Cash covers 1.6 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (2.4x) is below the industry median (4.0x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Anteris Technologies Global Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Anteris Technologies Global Corp

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenog…

Full company profile